Today
Correction: NextNRG to Host First Quarter 2026 Financial Results Conference Call on May 18, 2026 at 9:00 a.m. ET
an hour ago
SEEGNAL INC. ANNOUNCES FILING OF 2025 ANNUAL FILINGS AND THAT THE MCTO WILL NO LONGER BE IN EFFECT AS OF MAY 16, 2026
6 hours ago
Ellis Island Honors Society Presents the 2026 Ellis Island Medals of Honor
12 hours ago
Yesterday
ImmunityBio Signs Exclusive U.S. Agreement with Japan BCG Laboratory for the Tokyo Strain of BCG to Enhance BCG Supply in the United States
20 hours ago
Lilly, Caitlin Clark Foundation, and Musco Lighting open three community sports courts in Indianapolis, expanding year-round access for youth
a day ago
Ipsen presents first-in-class late-breaking Phase II corabotase data in glabellar lines showing sustained duration of effect reinforced by consistently high patient satisfaction
a day ago
/C O R R E C T I O N -- ArcelorMittal Exploitation minière Canada s.e.n.c./
a day ago
Western Union Company (the) Best Way to Send Money from Canada (2026): Western Union Recognized for Fast and Secure International Transfers by Better Business Advice
a day ago
nVent Announces Share Repurchase Authorization
a day ago
Dr. Reddy's Laboratories Ltd. Dr. Reddy's Laboratories Launches its Generic Semaglutide Injection in Canada
a day ago
Trillion Energy International Inc Trillion Provides Corporate Update
a day ago
Regency Silver Appoints Private Equity Fund Manager Alejandro Sucre to Board of Directors
a day ago
Entrepreneur Universe Bright Group Entrepreneur Universe Bright Group Reports First Quarter 2026 Financial Results
a day ago
Rio2 Reports First Quarter 2026 Financial Results and Operations Update
a day ago
Letter to the Shareholders
2 days ago
ImagineAR Announces Non-Brokered Private Placement Financing
2 days ago
Starbucks Corporation Announces Early Results and Upsizing of its Tender Offers for Eight Series of Notes
2 days ago
Go Residential Real Estate Investment Trust GO RESIDENTIAL REAL ESTATE INVESTMENT TRUST ESTABLISHES AUTOMATIC UNIT PURCHASE PLAN
2 days ago
Regeneron Pharmaceuticals, Inc. Regeneron Provides Update on Phase 3 Trial of Fianlimab (LAG-3 Inhibitor) Combination in First-Line Unresectable or Metastatic Melanoma
2 days ago
Ravelin Properties REIT Reports First Quarter 2026 Results
2 days ago
Google Übersetzer
